PI3K signaling in lymphocyte migration

Cell Cycle

Volumn 8, Issue 20, 2009, Pages 3307-3310

  Saudemont, Aurore ^a,c   Colucci, Francesco ^a,b  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Lymphocytes; Migration; Phosphoinositide 3 kinase (PI3K)

Indexed keywords

BETA2 INTEGRIN; CHEMOKINE RECEPTOR; CXCL13 CHEMOKINE; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; HETERODIMER; INTEGRIN; LEUKOTRIENE B4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE P110 DELTA SUBUNIT; PHOSPHATIDYLINOSITOL 3 KINASE P110 GAMMA SUBUNIT; PROTEIN KINASE SYK; PROTEIN SH2; PROTEIN TYROSINE KINASE; SECONDARY LYMPHOID TISSUE CHEMOKINE; SELECTIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

CELL METABOLISM; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CHEMOTAXIS; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; NATURAL KILLER CELL; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 70350243048     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.20.9692     Document Type: Review

References (52)

1. Katso R, Ahmadi K, White S, Timms J, Waterfield MD. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis and cancer. Annu Rev Cell Dev Biol 2001; 17:615-675 (Pubitemid 33096187)
2. Hawkins PT, Davidson K, Stephens LR. Signalling through Class I PI3Ks in mammalian cells. Biochem Soc Trans 2006; 34:647-662 (Pubitemid 44796393)
3. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 29:1655-1657
4. Ley K, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7:678-689 (Pubitemid 47327397)
5. Wang F, Weiner OD, Srinivasan S, Servant G, Bourne HR. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 2002; 4:513-518
6. Huang YE, Parent CA, Funamoto S, Firtel RA, Devreotes P. Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Mol Biol Cell 2003; 14:1913-1922.
7. Servant G, Herzmark P, Balla T, Sedat JW, Bourne HR. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 2000; 287:1037-1040 (Pubitemid 30094359)
8. Rickert P, Wang F, Bourne HR, Servant G. Leukocytes navigate by compass: roles of PI3Kgamma and its lipid products. Trends Cell Biol 2000; 10:466-473 (Pubitemid 30767764)
9. Sotsios Y, Ward S. Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines. Immunol Rev 2000; 177:217-235
10. Niggli V, KH. The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils. Eur J Pharmacol 1997; 335:43-52. (Pubitemid 27450468)
11. Vanhaesebroeck BJG, Allen WE, Zicha D, Hooshmand-Rad R, Sawyer C, Wells C, et al. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat Cell Biol 1999; 1:69-71.
12. Matheu MPDJ, Parker I, Fruman DA, Cahalan MD. Class IA phosphoinositide 3-kinase modulates basal lymphocyte motility in the lymph node. J Immunol 2007; 179:2261-2269
13. Reif K, Okkenhaug K, Sasaki T, Penninger JM, Vanhaesebroeck B, Cyster JG. Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 2004; 173:2236-2240 (Pubitemid 39063077)
14. Al-Aoukaty ARB, Maghazachi AA. Recruitment of pleckstrin and phosphoinositide 3-kinase gamma into the cell membranes, and their association with Gbetagamma after activation of NK cells with chemokines. J Immunol 1999; 162:3249-3255
15. Curnock APLM, Ward SG. Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases. Immunology 2002; 105:125-136
16. Jones GEPE, Calvez R, Hogan C, Dunn GA, Hirsch E, Wymann MP, et al. Requirement for PI3-kinase gamma in macrophage migration to MCP-1 and CSF-1. Exp Cell Res 2003; 290:120-131 (Pubitemid 37153256)
17. Guillermet-Guibert JBK, Salpekar A, Gonella C, Ramadani F, Bilancio A, Meek S, et al. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci USA 2008; 105:8292-8297 (Pubitemid 351904749)
18. Tilton BHL, Oberlin E, Loetscher P, Baleux F, Clark- Lewis I, Thelen M. Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med 2000; 192:313-324 (Pubitemid 30629157)
19. Condliffe AMDK, Anderson KE, Ellson CD, Crabbe T, Okkenhaug K, Vanhaesebroeck B, et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 2005; 106:1432-1440 (Pubitemid 41129612)
20. Liu LPK, Penninger JM, Kubes P. Leukocyte PI3Kgamma and PI3Kdelta have temporally distinct roles for leukocyte recruitment in vivo. J Immunol 2007; 110:1191-1198
21. Swat WMV, Doggett TA, Douangpanya J, Puri K, Vermi W, Diacovo TG. Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival. Blood 2006; 107:2415-2422 (Pubitemid 43345562)
22. Webb LM, Vigorito E, Wymann MP, Hirsch E, Turner M. Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase. J Immunol 2005; 175:2783-2787 (Pubitemid 41170493)
23. Kim N, Saudemont A, Webb L, Camps M, Ruckle T, Hirsch E, et al. The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion. Blood 2007; 110:3202-3208 (Pubitemid 350106312)
24. Tassi I, Cella M, Gilfillan S, Turnbull I, Diacovo TG, Penninger JM, et al. p110gamma and p110delta phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells. Immunity 2007; 27:214-227 (Pubitemid 47284932)
25. Graupera MG-GJ, Foukas LC, Phng LK, Cain RJ, Salpekar A, Pearce W, et al. Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature 2008; 453:662-666 (Pubitemid 351769296)
26. Puri KDDT, Douangpanya J, Hou Y, Tino WT, Wilson T, Graf T, et al. Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue. Blood 2004; 103:3448-3456 (Pubitemid 38525677)
27. Sinclair LVFD, Feijoo C, Cornish GH, Gray A, Ager A, Okkenhaug K, et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 2008; 9:513-521 (Pubitemid 351560520)
28. Jarmin SJDR, Ma L, Chai JG, Dewchand H, Takesono A, Ridley AJ, et al. T cell receptor-induced phosphoinositide-3-kinase p110delta activity is required for T cell localization to antigenic tissue in mice. J Clin Invest 2008; 118:1154-1164
29. Sawyer CSJ, Bennett DC, O'Hare MJ, Allen WE, Bain J, Jones GE, et al. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. Cancer Res 2003; 63:1667-1675 (Pubitemid 36373660)
30. Ali KBA, Thomas M, Pearce W, Gilfillan AM, Tkaczyk C, Kuehn N, et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 2004; 431:1007-1011 (Pubitemid 39434424)
31. Sadhu CMB, Dick K, Sowell CG, Staunton DE. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. J Immunol 2003; 170:2647-2654 (Pubitemid 36245657)
32. Martin ALSM, Jameson SC, Shimizu Y. Selective regulation of CD8 effector T cell migration by the p110gamma isoform of phosphatidylinositol 3-kinase. J Immunol 2008; 180:2081-2088
33. Laffargue MCR, Finan P, Trifilieff A, Barbier M, Altruda F, Hirsch E, et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 2002; 16:441-451 (Pubitemid 34260921)
34. Sasaki TI-SJ, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000; 287:1040-1046
35. Okkenhaug KBA, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, et al. Impaired B and T cell antigen receptor signaling in p110delta PI3-kinase mutant mice. Science 2002; 297:1031-1034 (Pubitemid 34856039)
36. Bilancio A, Okkenhaug K, Camps M, Emery JL, Ruckle T, Rommel C, et al. Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood 2006; 107:642-650 (Pubitemid 43076389)
37. Okkenhaug K, Patton D, Bilancio A, Garçon F, Rowan WC, Vanhaesebroeck B. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J Immunol 2006; 177:5122-5128 (Pubitemid 44527583)
38. Patton DTGO, Pearce WP, Clough LE, Monk CR, Leung E, Rowan WC, et al. Cutting edge: the phosphoinositide 3-kinase p110delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 2006; 177:6598-6602
39. Crabbe TWM, Ward SG. The PI3K inhibitor arsenal: choose your weapon! Trends Biochem Sci 2007; 32:450-456
40. Barber DFBA, Hernandez C, Flores JM, Redondo C, Fernandez-Arias C, Camps M, et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 2005; 11:933-935 (Pubitemid 41294437)
41. Camps MRT, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005; 11:936-943 (Pubitemid 41294438)
42. Firestein GS. Inhibiting inflammation in rheumatoid arthritis.N Engl J Med 2006; 354:80-82
43. Randis TMPK, Zhou H, Diacovo TG. Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils. Eur J Immunol 2008; 38:1215-1224
44. Rommel CCM, Ji H. PI3Kdelta and PI3Kgamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 2007; 7:191-201.
45. Lee KSLH, Hayflick JS, Lee YC, Puri KD. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 2006; 20:455-465 (Pubitemid 44933322)
46. Takeda MIW, Tanabe M, Ueki S, Kato H, Kihara J, Tanigai T, et al. Allergic airway hyperresponsiveness, inflammation and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice. J Allergy Clin Immunol 2009; 123:805-812
47. Thomas MJSA, Head DH, Milne L, Nicholls A, Pearce W, Vanhaesebroeck B, et al. Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. Eur J Immunol 2005; 35:1283-1291 (Pubitemid 40542236)
48. Walzer TCL, Chaix J, Calver A, Carozzo C, Garrigue-Antar L, Jacques Y, et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 2007; 8:1337-1344 (Pubitemid 350131171)
49. Schwab SR, Cyster J. Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 2007; 8:1295-1301 (Pubitemid 350131168)
50. Saudemont A, Garcon F, Yadi H, Roche-Molina M, Kim N, Segonds-Pichon A, et al. p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proc Natl Acad Sci USA 2009; 106:5795-5800
51. Schymeinsky JTC, Sindrilaru A, Gerstl R, Jakus Z, Tybulewicz VL, Scharffetter-Kochanek K, et al. Sykmediated translocation of PI3Kdelta to the leading edge controls lamellipodium formation and migration of leukocytes. PLoS ONE 2007; 2:1132. (Pubitemid 351594025)
52. Kumar AHT, Kremer KN, Bramati PS, Bradfield L, Edgar CE, Hedin K. CXCR4 physically associates with the T cell receptor to signal in T cells. Immunity 2006; 25:213-224 (Pubitemid 44224150)